Kevin McElgunn
Corporate Officer/Principal chez MYERS INDUSTRIES, INC.
Postes actifs de Kevin McElgunn
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| MYERS INDUSTRIES, INC. | Corporate Officer/Principal | 01/06/2022 | - |
Historique de carrière de Kevin McElgunn
Anciens postes connus de Kevin McElgunn
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Dow Chemical Corporate Venture Capital
 Dow Chemical Corporate Venture Capital Investment ManagersFinance Dow Chemical Corporate Venture Capital (DCCVC) is a venture capital firm subsidiary of Dow Chemical Co. (NYSE:DOW) founded in 1994. The firm is headquartered in Midland, Michigan. | Private Equity Investor | 08/02/2011 | 01/03/2018 |
| PFENEX INC. | Directeur/Membre du Conseil | - | - |
Formation de Kevin McElgunn
| Kansas State University | Undergraduate Degree |
| Northwood University (Michigan) | Masters Business Admin |
Statistiques
Internationale
| Etats-Unis | 6 |
Opérationnelle
| Private Equity Investor | 1 |
| Undergraduate Degree | 1 |
| Masters Business Admin | 1 |
Sectorielle
| Consumer Services | 3 |
| Finance | 2 |
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| MYERS INDUSTRIES, INC. | Producer Manufacturing |
| Entreprise privées | 2 |
|---|---|
Dow Chemical Corporate Venture Capital
Dow Chemical Corporate Venture Capital Investment ManagersFinance Dow Chemical Corporate Venture Capital (DCCVC) is a venture capital firm subsidiary of Dow Chemical Co. (NYSE:DOW) founded in 1994. The firm is headquartered in Midland, Michigan. | Finance |
Pelican Inc
 Pelican Inc BiotechnologyHealth Technology Pfenex, Inc. is a development and licensing Biotechnology Company, which focuses on leveraging its Pfenex Expression Technology platform for developing and improving protein therapies. Its products include PF708, PF743, PF745, CRM197, PF810, PF753 and PFXX. The company was founded on November 19, 2009 and is headquartered in San Diego, CA. | Health Technology |
- Bourse
- Insiders
- Kevin McElgunn
- Expérience